Skip to main content
All lobbying filings

SKINCURE ONCOLOGY

SKINCURE ONCOLOGY filed a Q4 amendment for SKINCURE ONCOLOGY on January 20, 2026.

Lobbying for SKINCURE ONCOLOGY · Provider of non-surgical treatment option for skin cancer patients

All filings by SKINCURE ONCOLOGY · Everything SKINCURE ONCOLOGY has reported

 Filing · LD-2 quarterly report Q4 amendment
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$120,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Illinois

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Education and provision of information regarding Image Guided Superficial Radiation therapy (IGSRT) while working on a coverage policy with CMS for IGSRT.

Education and provision of information regarding Image Guided Superficial Radiation therapy (IGSRT) while working on a coverage policy with CMS for IGSRT.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem